Discrepancy between [18F]-FES and [18F]-FDG PET/CT in ER-positive breast cancer with oesophageal metastasis-Reference-Cited by-同舟云学术

Discrepancy between [18F]-FES and [18F]-FDG PET/CT in ER-positive breast cancer with oesophageal metastasis

Published:2022-04-01 Issue:9 Volume:49 Page:3297-3298
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Kiatkittikul Peerapon^ORCID,Promteangtrong Chetsadaporn,Kunawudhi Anchisa,Siripongsatian Dheeratama,Chotipanich Chanisa

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00259-022-05759-z.pdf

Reference7 articles.

1. Su H, Wu J, Liu H, Wei N, Lin W, Zhou Q, Wang M, Lv S, Yang Y. Review of esophageal metastasis from breast cancer. Gland Surg. 2020;9:417–22.

2. Research C for DE and. Drug Trial Snapshot: CERIANNA. FDA [Internet]. FDA. 2020. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trial-snapshot-cerianna. Accessed 8 Jul 2021.

3. Gupta M, Datta A, Choudhury PS, Dsouza M, Batra U, Mishra A. Can 18F-fluoroestradiol positron emission tomography become a new imaging standard in the estrogen receptor-positive breast cancer patient: a prospective comparative study with 18F-fluorodeoxyglucose positron emission tomography? World J Nucl Med. 2017;16:133–9.

4. Chae SY, Ahn SH, Kim SB, Han S, Lee SH, Oh SJ, Lee SJ, Kim HJ, Ko BS, Lee JW, Son BH, Kim J, Ahn JH, Jung KH, Kim JE, Kim SY, Choi WJ, Shin HJ, Gong G, Lee HS, Lee JB, Moon DH. Diagnostic accuracy and safety of 16α-[18F]fluoro-17β-oestradiol PET-CT for the assessment of oestrogen receptor status in recurrent or metastatic lesions in patients with breast cancer: a prospective cohort study. Lancet Oncol. 2019;20:546–55.

5. Chae SY, Son HJ, Lee DY, Shin E, Oh JS, Seo SY, Baek S, Kim JY, Na SJ, Moon DH. Comparison of diagnostic sensitivity of [18F]fluoroestradiol and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer. EJNMMI Res. 2020;10:54.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. <sup>18</sup>F-FES PET/CT Research Progress in the Diagnosis and Treatment of Breast Cancer;Journal of Biosciences and Medicines;2024

2. Robust ERα-Targeted Near-Infrared Fluorescence Probe for Selective Hydrazine Imaging in Breast Cancer;Analytical Chemistry;2022-09-27

3. Letrozole;Reactions Weekly;2022-08-13